318 related articles for article (PubMed ID: 19929986)
1. Genome-wide SNP genotyping study using pooled DNA to identify candidate markers mediating susceptibility to end-stage renal disease attributed to Type 1 diabetes.
Craig DW; Millis MP; DiStefano JK
Diabet Med; 2009 Nov; 26(11):1090-8. PubMed ID: 19929986
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide search for susceptibility gene to diabetic nephropathy by gene-based SNP.
Maeda S
Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S45-7. PubMed ID: 15563979
[TBL] [Abstract][Full Text] [Related]
3. Variants in the plasmacytoma variant translocation gene (PVT1) are associated with end-stage renal disease attributed to type 1 diabetes.
Millis MP; Bowen D; Kingsley C; Watanabe RM; Wolford JK
Diabetes; 2007 Dec; 56(12):3027-32. PubMed ID: 17881614
[TBL] [Abstract][Full Text] [Related]
4. Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study.
Hanson RL; Craig DW; Millis MP; Yeatts KA; Kobes S; Pearson JV; Lee AM; Knowler WC; Nelson RG; Wolford JK
Diabetes; 2007 Apr; 56(4):975-83. PubMed ID: 17395743
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.
Buraczynska M; Ksiazek P; Drop A; Zaluska W; Spasiewicz D; Ksiazek A
Nephrol Dial Transplant; 2006 Apr; 21(4):979-83. PubMed ID: 16384824
[TBL] [Abstract][Full Text] [Related]
6. A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study.
Zhang D; Ma J; Brismar K; Efendic S; Gu HF
J Diabetes Complications; 2009; 23(4):265-72. PubMed ID: 18599322
[TBL] [Abstract][Full Text] [Related]
7. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
8. Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy.
McKnight AJ; Savage DA; Patterson CC; Sadlier D; Maxwell AP
BMC Med Genet; 2007 Feb; 8():5. PubMed ID: 17319955
[TBL] [Abstract][Full Text] [Related]
9. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
Buraczynska M; Swatowski A; Buraczynska K; Dragan M; Ksiazek A
Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel candidate genes for type 2 diabetes from a genome-wide association scan in the Old Order Amish: evidence for replication from diabetes-related quantitative traits and from independent populations.
Rampersaud E; Damcott CM; Fu M; Shen H; McArdle P; Shi X; Shelton J; Yin J; Chang YP; Ott SH; Zhang L; Zhao Y; Mitchell BD; O'Connell J; Shuldiner AR
Diabetes; 2007 Dec; 56(12):3053-62. PubMed ID: 17846126
[TBL] [Abstract][Full Text] [Related]
11. Estimation of single nucleotide polymorphism allele frequency in DNA pools by using Pyrosequencing.
Gruber JD; Colligan PB; Wolford JK
Hum Genet; 2002 May; 110(5):395-401. PubMed ID: 12073008
[TBL] [Abstract][Full Text] [Related]
12. CD2AP is associated with end-stage renal disease in patients with type 1 diabetes.
Hyvönen ME; Ihalmo P; Sandholm N; Stavarachi M; Forsblom C; McKnight AJ; Lajer M; Maestroni A; Lewis G; Tarnow L; Maestroni S; Zerbini G; Parving HH; Maxwell AP; Groop PH; Lehtonen S
Acta Diabetol; 2013 Dec; 50(6):887-97. PubMed ID: 23681557
[TBL] [Abstract][Full Text] [Related]
13. The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus.
Ksiazek P; Bednarek-Skublewska A; Buraczyńska M
Med Sci Monit; 2004 Feb; 10(2):BR47-51. PubMed ID: 14737040
[TBL] [Abstract][Full Text] [Related]
14. Identification of disease causing loci using an array-based genotyping approach on pooled DNA.
Craig DW; Huentelman MJ; Hu-Lince D; Zismann VL; Kruer MC; Lee AM; Puffenberger EG; Pearson JM; Stephan DA
BMC Genomics; 2005 Sep; 6():138. PubMed ID: 16197552
[TBL] [Abstract][Full Text] [Related]
15. Common polymorphisms of the PAI1 gene do not play a major role in the development of diabetic nephropathy in Type 1 diabetes.
Martin RJ; Savage DA; Patterson CC; Brady HR; Maxwell AP
Diabet Med; 2007 Mar; 24(3):259-65. PubMed ID: 17263760
[TBL] [Abstract][Full Text] [Related]
16. Role of non-HLA genetic variants in end-stage renal disease.
Ranganath P; Tripathi G; Sharma RK; Sankhwar SN; Agrawal S
Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039
[TBL] [Abstract][Full Text] [Related]
17. Assessing genetic susceptibility to diabetic nephropathy.
Tanaka N; Babazono T
Nephrology (Carlton); 2005 Oct; 10 Suppl():S17-21. PubMed ID: 16174281
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the association of BMP gene variants with nephropathy in Type 1 diabetes mellitus.
McKnight AJ; Pettigrew KA; Patterson CC; Kilner J; Sadlier DM; Maxwell AP;
Diabet Med; 2010 Jun; 27(6):624-30. PubMed ID: 20546278
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease.
Babel N; Gabdrakhmanova L; Hammer MH; Schoenemann C; Skrypnikov V; Poliak N; Volk HD; Reinke P
J Nephrol; 2006; 19(6):802-7. PubMed ID: 17173255
[TBL] [Abstract][Full Text] [Related]
20. Investigation of P213S SELL gene polymorphism in type 2 diabetes mellitus and related end stage renal disease. A case-control study.
Stavarachi M; Panduru NM; Serafinceanu C; Moţa E; Moţa M; Cimponeriu D; Ion DA
Rom J Morphol Embryol; 2011; 52(3 Suppl):995-8. PubMed ID: 22119815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
